Two patients have been treated using RPE (retinal pigment epithelial) cells derived from hESCs (human embryonic stem cells) in two Phase 1/2 clinical trials for dry age-related macular degeneration and Stargardt’s macular dystrophy, Advanced Cell Techn…
Transcend Medical Closes $51M Series B Financing
Transcend Medical, Inc., an ophthalmic device company dedicated to developing minimally invasive glaucoma therapies, announced the closure of its second tranche, bringing the total of Series B to $51M. Investor Growth Capital (IGC) joined this tranche,…
Histopathologic Complications Seen Post-Intra-Arterial Chemo
Though retinoblastoma can be controlled by intra-arterial chemotherapy (IAC), histopathology demonstrates that ocular complications, including thromboembolic events, can occur, according to a study published online July 11 in the Archives of Ophthalmol…
ACT Announces First Patients Undergo Embryonic Stem Cell Transplantation Treatment For Stargardt’s Disease And Macular Degeneration At UCLA’s Jules Stein Eye Institute
Advanced Cell Technology, Inc. , a leader in the field of regenerative medicine, today announced the dosing of the first patients in each of its two Phase 1/2 clinical trials for Stargardt’s macular dystrophy and dry age-related macular degeneration (d…
Transcend Medical Closes $51M Series B Financing
Transcend Medical, Inc., an ophthalmic device
company dedicated to developing minimally invasive glaucoma therapies,
announced the closure of its second tranche, bringing the total of Series B to $51M.
Introduction to the Reichert Reflex UBM and Clearscan(R) ultrasound probe cover
Learn how the Reichert Reflex Ultrasound Biomicroscope, combined with innovative ClearScan (R) probe covers, enables operators to easily image the anterior and posterior segments of the eye.